Trifluoperazine induces apoptosis through the upregulation of Bax/Bcl‑2 and downregulated phosphorylation of AKT in mesangial cells and improves renal function in lupus nephritis mice

Wang,Baodong; Luo,Yankun; Zhou,Xiaoshuang; Li,Rongshan

doi:10.3892/ijmm.2018.3562

Trifluoperazine induces apoptosis through the upregulation of Bax/Bcl‑2 and downregulated phosphorylation of AKT in mesangial cells and improves renal function in lupus nephritis mice

Authors:
- Baodong Wang
- Yankun Luo
- Xiaoshuang Zhou
- Rongshan Li
View Affiliations

Affiliations: Department of Nephrology, The Affiliated People's Hospital of Shanxi Medical University, Shanxi Provincial People's Hospital, Shanxi Kidney Disease Institute, Taiyuan, Shanxi 030001, P.R. China
Published online on: March 13, 2018 https://doi.org/10.3892/ijmm.2018.3562
Pages: 3278-3286
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The inhibition of mesangial cell (MC) proliferation has become an important therapy in preventing glomerular proliferation diseases. Trifluoperazine (TFP) has been reported to inhibit the proliferation of several types of cancer cell, however, the effects of TFP in renal proliferation diseases remain to be fully elucidated. The present study examined the effects of TFP on the proliferation of MCs and quantified cell apoptosis progression in vivo and in vitro. The effects of various TFP concentrations and treatment durations on cell proliferation and cell apoptosis in vitro were analyzed using flow cytometry in conjunction with a Cell Counting kit‑8 assay. Cell proliferation in vivo was determined using hematoxylin and eosin staining and immunohistochemistry of Ki67. The expression of the two cell apoptosis‑related proteins, B‑cell lymphoma-2 (Bcl‑2) and Bcl‑2‑associated X protein (Bax), were estimated using western blot analysis and immunohistochemistry in vivo and in vitro. TFP‑induced phosphatidylinositol 3‑kinase (PI3K)/protein kinase B (AKT) signaling pathways were also estimated using western blot analysis. These results suggested that TFP inhibited MC proliferation in a dose‑ and time‑dependent manner. It was found that TFP inhibited the abnormal proliferation of MCs, which was stimulated by 20% fetal bovine serum in vitro and in lupus MRL/lpr mice. TFP promoted cell apoptosis, downregulated the expression of Bcl‑2 and upregulated the expression of Bax in a dose‑dependent manner at mRNA and protein levels. In addition, TFP inhibited phosphorylated AKT, potentially leading to the suppressed activation of PI3K/AKT signaling pathways. TFP treatment significantly decreased the levels of blood urea nitrogen and serum creatinine, but had no significant effects on the body weight and liver function of the lupus mice. These results validated and reinforced the potential of TFP in the treatment of mesangial proliferative diseases.

View Figures

View References

1	Badr KF, Murray JJ, Breyer MD, Takahashi K, Inagami T and Harris RC: Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways. J Clin Invest. 83:336–342. 1989. View Article : Google Scholar : PubMed/NCBI
2	Wyatt RJ and Julian BA: IgA nephropathy. N Engl J Med. 368:2402–2414. 2013. View Article : Google Scholar : PubMed/NCBI
3	Grassmann A, Gioberge S, Moeller S and Brown G: ESRD patients in 2004: Global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant. 20:2587–2593. 2005. View Article : Google Scholar : PubMed/NCBI
4	Matsumoto K, Yoshikai Y, Asano T, Himeno K, Iwasaki A and Nomoto K: Defect in negative selection in lpr donor-derived T cells differentiating in non-lpr host thymus. J Exp Med. 173:127–136. 1991. View Article : Google Scholar : PubMed/NCBI
5	Sugiyama N, Nakashima H, Yoshimura T, Sadanaga A, Shimizu S, Masutani K, Igawa T, Akahoshi M, Miyake K, Takeda A, et al: Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor alpha (WSX-1). Ann Rheum Dis. 67:1461–1467. 2008. View Article : Google Scholar
6	Lamoureux JL, Watson LC, Cherrier M, Skog P, Nemazee D and Feeney AJ: Reduced receptor editing in lupus-prone MRL/lpr mice. J Exp Med. 204:2853–2864. 2011. View Article : Google Scholar
7	Johnstone RW, Ruefli AA and Lowe SW: Apoptosis: A link between cancer genetics and chemotherapy. Cell. 108:153–164. 2002. View Article : Google Scholar : PubMed/NCBI
8	Brunelle JK and Letai A: Control of mitochondrial apoptosis by the Bcl-2 family. J Cell Sci. 122:437–441. 2009. View Article : Google Scholar : PubMed/NCBI
9	Czabotar PE, Lessene G, Strasser A and Adams JM: Control of apoptosis by the BCL-2 protein family: Implications for physiology and therapy. Nat Rev Mol Cell Biol. 15:49–63. 2014. View Article : Google Scholar
10	Uda S, Yoshimura A, Sugenoya Y, Inui K, Taira T and Ideura T: Mesangial proliferative nephritis in man is associated with increased expression of the cell survival factor, Bcl-2. Am J Nephrol. 18:291–295. 1998. View Article : Google Scholar : PubMed/NCBI
11	Zhuan B, Ding Y, Zhang H and Yu Y: Effects of Xueniaoting powder and S-9 on apoptosis and expression of bax and bcl-2 in glomerular mesangial cells. Shenzhen J Integ Trad Chin Western Med. 13:447–456. 2003.
12	Zhuan B, Ding Y and Wu L: Effects of shenbining on apoptosis and experssion of bax and Bcl-2 in the kidney of mesangial proliferative glomerulonephritis. Chin J Integ Trad Western Nephrol. 4:316–318. 2003.
13	Franke TF, Hornik CP, Segev L, Shostak GA and Sugimoto C: PI3K/Akt and apoptosis: Size matters. Oncogene. 22:8983–8998. 2003. View Article : Google Scholar : PubMed/NCBI
14	Gao T, Furnari F and Newton AC: PHLPP: A phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell. 18:13–24. 2005. View Article : Google Scholar : PubMed/NCBI
15	Gong AJ, Gong LL, Yao WC, Ge N, Lu LX and Liang H: Aplysin induces apoptosis in glioma cells through HSP90/AKT pathway. Exp Biol Med (Maywood). 240:639–644. 2015. View Article : Google Scholar
16	Chen WS, Xu PZ, Gottlob K, Chen ML, Sokol K, Shiyanova T, Roninson I, Weng W, Suzuki R, Tobe K, et al: Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 15:2203–2208. 2001. View Article : Google Scholar : PubMed/NCBI
17	Stylianou K, Petrakis I, Mavroeidi V, Stratakis S, Vardaki E, Perakis K, Stratigis S, Passam A, Papadogiorgaki E, Giannakakis K, et al: The PI3K/Akt/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin. Nephrol Dialy Transplant. 26:498–508. 2011. View Article : Google Scholar
18	Gulino A, Barrera G, Vacca A, Farina A, Ferretti C, Screpanti I, Dianzani MU and Frati L: Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells. Cancer Res. 46:6274–6278. 1986.PubMed/NCBI
19	Chen QY, Wu LJ, Wu YQ, Lu GH, Jiang ZY, Zhan JW, Jie Y and Zhou JY: Molecular mechanism of trifluoperazine induces apoptosis in human A549 lung adenocarcinoma cell lines. Mol Med Rep. 2:811–817. 2009. View Article : Google Scholar : PubMed/NCBI
20	Polischouk AG, Holgersson A, Zong D, Stenerlöw B, Karlsson HL, Möller L, Viktorsson K and Lewensohn R: The antipsychotic drug trifluoperazine inhibits DNA repair and sensitizes non small cell lung carcinoma cells to DNA double-strand break induced cell death. Mol Cancer Ther. 6:2303–2309. 2007. View Article : Google Scholar : PubMed/NCBI
21	Yeh CT, Wu AT, Chang PM, Chen KY, Yang CN, Yang SC, Ho CC, Chen CC, Kuo YL, Lee PY, et al: Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer. Am J Respir Crit Care Med. 186:1180–1188. 2012. View Article : Google Scholar : PubMed/NCBI
22	Delarue F, Virone A, Hagege J, Lacave R, Peraldi MN, Adida C, Rondeau E, Feunteun J and Sraer JD: Stable cell line of T-SV40 immortalized human glomerular visceral epithelial cells. Kidney Int. 40:906–912. 1991. View Article : Google Scholar : PubMed/NCBI
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
24	Savill J, Mooney A and Hughes J: Apoptosis and renal scarring. Kidney Int Suppl. 54:S14–S17. 1996.PubMed/NCBI
25	Adams JM and Cory S: The Bcl-2 protein family: Arbiters of cell survival. Science. 281:1322–1326. 1998. View Article : Google Scholar : PubMed/NCBI
26	Hong SH, Lee MY, Shin KS and Kang SJ: Perphenazine and trifluoperazine induce mitochondria-mediated cell death in SH-SY5Y cells. Animal Cells Syst. 16:20–26. 2012. View Article : Google Scholar
27	Cui JH, Qiao Q, Guo Y, Zhang YQ, Cheng H, He FR and Zhang J: Increased apoptosis and expression of FasL, Bax and caspase-3 in human lupus nephritis class II and IV. J Nephrol. 25:255–261. 2012. View Article : Google Scholar
28	Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signalling pathway and cancer. Cancer Treat Rev. 30:193–204. 2004. View Article : Google Scholar : PubMed/NCBI
29	Kim AH, Khursigara G, Sun X, Franke TF and Chao MV: Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol. 21:893–901. 2001. View Article : Google Scholar : PubMed/NCBI
30	Majumder PK and Sellers WR: Akt-regulated pathways in prostate cancer. Oncogene. 24:7465–7474. 2005. View Article : Google Scholar : PubMed/NCBI
31	Shimamura H, Terada Y, Okado T, Tanaka H, Inoshita S and Sasaki S: The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-kappa B and Bad. J Am Soc Nephrol. 14:1427–1434. 2003. View Article : Google Scholar : PubMed/NCBI
32	Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR and Tsichlis PN: The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 81:727–736. 1995. View Article : Google Scholar : PubMed/NCBI
33	Howland RH: Trifluoperazine: A sprightly old drug. J Psychosoc Nurs Ment Health Serv. 54:20–22. 2016. View Article : Google Scholar : PubMed/NCBI